Sept 13 (Reuters) - Roche Holding AG ROG.S :
* HERCEPTIN® (TRASTUZUMAB) SUBCUTANEOUS (SC) FORMULATION APPROVED IN CANADA FOR TREATMENT OF HER2-POSITIVE BREAST CANCER
Sept 13 (Reuters) - Roche Holding AG ROG.S :
* HERCEPTIN® (TRASTUZUMAB) SUBCUTANEOUS (SC) FORMULATION APPROVED IN CANADA FOR TREATMENT OF HER2-POSITIVE BREAST CANCER